S&P 500   3,979.67 (+0.22%)
DOW   32,461.47 (+0.69%)
QQQ   308.60 (-0.74%)
AAPL   158.24 (-1.25%)
MSFT   276.01 (-1.63%)
META   202.22 (-1.84%)
GOOGL   102.28 (-3.00%)
AMZN   97.42 (-0.72%)
TSLA   191.57 (+0.61%)
NVDA   265.80 (-0.74%)
NIO   8.91 (-1.76%)
BABA   85.66 (-1.43%)
AMD   96.06 (-1.93%)
T   18.87 (+1.40%)
F   11.48 (-0.26%)
MU   59.99 (-1.91%)
CGC   1.89 (-0.79%)
GE   93.15 (+1.95%)
DIS   95.07 (+1.05%)
AMC   4.38 (-2.01%)
PFE   40.33 (-0.15%)
PYPL   73.61 (-0.37%)
NFLX   326.69 (-0.52%)
S&P 500   3,979.67 (+0.22%)
DOW   32,461.47 (+0.69%)
QQQ   308.60 (-0.74%)
AAPL   158.24 (-1.25%)
MSFT   276.01 (-1.63%)
META   202.22 (-1.84%)
GOOGL   102.28 (-3.00%)
AMZN   97.42 (-0.72%)
TSLA   191.57 (+0.61%)
NVDA   265.80 (-0.74%)
NIO   8.91 (-1.76%)
BABA   85.66 (-1.43%)
AMD   96.06 (-1.93%)
T   18.87 (+1.40%)
F   11.48 (-0.26%)
MU   59.99 (-1.91%)
CGC   1.89 (-0.79%)
GE   93.15 (+1.95%)
DIS   95.07 (+1.05%)
AMC   4.38 (-2.01%)
PFE   40.33 (-0.15%)
PYPL   73.61 (-0.37%)
NFLX   326.69 (-0.52%)
S&P 500   3,979.67 (+0.22%)
DOW   32,461.47 (+0.69%)
QQQ   308.60 (-0.74%)
AAPL   158.24 (-1.25%)
MSFT   276.01 (-1.63%)
META   202.22 (-1.84%)
GOOGL   102.28 (-3.00%)
AMZN   97.42 (-0.72%)
TSLA   191.57 (+0.61%)
NVDA   265.80 (-0.74%)
NIO   8.91 (-1.76%)
BABA   85.66 (-1.43%)
AMD   96.06 (-1.93%)
T   18.87 (+1.40%)
F   11.48 (-0.26%)
MU   59.99 (-1.91%)
CGC   1.89 (-0.79%)
GE   93.15 (+1.95%)
DIS   95.07 (+1.05%)
AMC   4.38 (-2.01%)
PFE   40.33 (-0.15%)
PYPL   73.61 (-0.37%)
NFLX   326.69 (-0.52%)
S&P 500   3,979.67 (+0.22%)
DOW   32,461.47 (+0.69%)
QQQ   308.60 (-0.74%)
AAPL   158.24 (-1.25%)
MSFT   276.01 (-1.63%)
META   202.22 (-1.84%)
GOOGL   102.28 (-3.00%)
AMZN   97.42 (-0.72%)
TSLA   191.57 (+0.61%)
NVDA   265.80 (-0.74%)
NIO   8.91 (-1.76%)
BABA   85.66 (-1.43%)
AMD   96.06 (-1.93%)
T   18.87 (+1.40%)
F   11.48 (-0.26%)
MU   59.99 (-1.91%)
CGC   1.89 (-0.79%)
GE   93.15 (+1.95%)
DIS   95.07 (+1.05%)
AMC   4.38 (-2.01%)
PFE   40.33 (-0.15%)
PYPL   73.61 (-0.37%)
NFLX   326.69 (-0.52%)
NASDAQ:BLPH

Bellerophon Therapeutics - BLPH Insider Trading & Ownership

$7.56
-0.31 (-3.94%)
(As of 03/27/2023 01:14 PM ET)
Add
Compare
Today's Range
$7.42
▼
$8.41
50-Day Range
$1.27
▼
$7.87
52-Week Range
$0.67
▼
$8.44
Volume
101,198 shs
Average Volume
2.38 million shs
Market Capitalization
$73.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.00

Bellerophon Therapeutics (NASDAQ:BLPH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
24.70%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
0

BLPH Insider Buying and Selling by Quarter

Get BLPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bellerophon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Bellerophon Therapeutics Insider Trades History

Export to Excel
(Data available from 1/1/2013 forward)












BLPH Insider Trading Activity - Frequently Asked Questions

Who is on Bellerophon Therapeutics's Insider Roster?

The list of insiders at Bellerophon Therapeutics includes New Mountain Investments Ii, L, and Wassim Fares. Learn more on insiders at BLPH.

What percentage of Bellerophon Therapeutics stock is owned by insiders?

24.70% of Bellerophon Therapeutics stock is owned by insiders. Learn more on BLPH's insider holdings.

This page (NASDAQ:BLPH) was last updated on 3/27/2023 by MarketBeat.com Staff